Form 8-K - Current report:
SEC Accession No. 0001104659-24-109368
Filing Date
2024-10-17
Accepted
2024-10-17 07:00:22
Documents
13
Period of Report
2024-10-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426302d1_8k.htm   iXBRL 8-K 24297
  Complete submission text file 0001104659-24-109368.txt   196283

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fold-20241015.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20241015_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20241015_pre.xml EX-101.PRE 22379
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2426302d1_8k_htm.xml XML 3552
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 241375909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)